Intravitreal Ranibizumab for Treatment of Posttraumatic Choroidal Neovascularization: a Case Report

An analysis of the case of applying a course of fibrinolytic therapy and one intravitreal injection of an angiogenesis inhibitor in a patient with traumatic rupture of the choroid complicated by choroidal neovascularization (CNV) is presented. Patient B., 20 years old, complained of a lack of objective vision after a blunt injury to his right eye in March 2018. Visual acuity decreased to 0.01 (ETDRS 0 characters). During the examination revealed: partial hemophthalmus, rupture of the choroid, Berlin retinal opacification. Local fibrinolytic conservative therapy with positive dynamics was carried out in the form of increasing visual acuity to 0.3 (ETDRS 21 characters) and partial resolution of hemophthalmus. According to optical coherence tomography angiography (OCTA), minimally active CNV was detected. Due to the weak activity of the pathological process, a decision was made on dynamic observation. A follow-up examination in August 2018 revealed an increase in CNV activity according to OCTA and fluorescence angiography (FAG), in connection with which intravitreal administration of ranibizumab (lucentis) was performed. Subsequently, the patient was under dynamic observation for one year. Positive dynamics was revealed in the form of an increase in visual acuity, first to 0.7 (ETDRS 48 characters) 3 months after intravitreal injection, and after a year — to 0.9 (ETDRS 55 characters). After treatment according to OCTA and FAG, the activity of CNV was not determined. Despite the favorable result of treatment, further monitoring of the patient is necessary, since the long-term prospects for maintaining the achieved high visual functions remain unclear due to the insufficient experience in treating patients with this pathology according to the literature.

1. Ament C.S. Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture. Archives of ophthalmology. 2006;124(7):957–966. DOI: 10.1001/archopht.124.7.957

2. Boiko E.V., Sosnovskii S.V., Beresin R.D., Koskin S.A., Yan A.V., Kulikov A.N., Malcev D.A., Butikova O.V., Davidova V.V., Jukova K.E. Antiangiogennaya terapiya v oftalmologii. St. Petersburg: VmedA S.M. Kirova; 2013. P. 113–121 (In Russ.).

3. Liggett P.E., Pince K.J., Barlow W., Ragen M., Ryan S.J. Ocular trauma in an urban population. Review of 1132 cases. Ophthalmology. 1990;97(5):581–584. DOI: 10.1016/S0161-6420(90)32539-3

4. Mehta H.B., Shanmugam M.P. Photodynamic therapy of a posttraumatic choroidal neovascular membrane. Indian journal of Ophthalmology. 2005;53:131–132. DOI: 10.4103/0301-4738.16180

5. Harissi-Dagher M., Sebag M., Gauthier D., Marcil G., Labelle P., Arbour J.D. Photodynamic therapy in young patients with choroidal neovascularization following traumatic choroidal rupture. American journal of ophthalmology. 2005;139(4):726–728. DOI: 10.1016/j.ajo.2004.10.009

6. Mennel S., Hausmann N., Meyer C.H., Peter S. Photodynamic therapy and indocyanine green guided feeder vessel photocoagulation of choroidal neovascularization secondary to choroid rupture after blunt trauma. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2005;243(1):68–71. DOI: 10.1007/s00417-0040964-1

7. Abdul-Salim I., Embong Z., Khairy-Shamel S.T., Raja-Azmi M.N. Intravitreal ranibizumab in treating extensive traumatic submacular hemorrhage. Clinical ophthalmology. 2013;7:703–706. DOI: 10.2147/OPTH.S42208

8. Moon K., Kim K. S., Kimb Y. C., A Case of Expansion of Traumatic Choroidal Rupture with Delayed-Developed Outer Retinal Changes. Case Reports in Ophthalmology. 2013;4(2):70–75. DOI: 10.1159/000354197

9. Prasad A., Patel C., Puklin J. Intravitreal bevacizumab in the treatment of choroidal neovascularization from a traumatic choroidal rupturein a 9-yearold child. Retinal Cases & Brief Reports. 2009;3(2):125–127. DOI: 10.1097/ICB.0b013e31815e9903

10. Rishi P., Shroff D., Rishi E. Intravitreal bevacizumab in the management of posttraumatic choroidal neovascular membrane. Retinal Cases & Brief Reports. 2008;2(3):236–238. DOI: 10.1097/ICB.0b013e31815e9419

11. White M.F., Morris R., Feist R.M., Witherspoon C.D., Helms H.A., John G.R. Eye injury: prevalence and prognosis by setting. Southern Medical Journal. 1989;82(2):151–158. DOI: 10.3928/1542-8877-19920601-10

12. Wong T.Y., Ohno-Matsui K., Leveziel N., Holz F.G., Lai T.Y., Yu H.G., Lanzetta P., Chen Y., Tufail A. Myopic choroidal neovascularisation: current concepts and update on clinical management. British Journal of Ophthalmology. 2015;99(3):289–296. DOI: 10.1136/bjophthalmol-2014-305131